Search
for
Sort by
Research 91–120 of 1000+
- Fibroblast heterogeneity and tertiary lymphoid tissues in the kidney
- Redefining hormone resistance in prostate cancer
- Stem Cells and the Niche: A Dynamic Duo
- Exploring the Drug Repurposing Versatility of Valproic Acid as a Multifunctional Regulator of Innate and Adaptive Immune Cells
- Next-Gen Therapeutics for Skin Cancer: Nutraceuticals
- Indian Gooseberry (<i>Emblica officinalis</i>Gaertn.)
- Expression of COX-2 and Bcl-2 in 50 patients of Lichen Planus
- Hormesis and medicine
- Red ginseng monograph
- Chemotherapy-induced alopecia
- The HEDGEHOG-GLI1 pathway is important for fibroproliferative properties in keloids and as a candidate therapeutic target
- The molecular pathogenesis of Trichilemmal carcinoma
- Design and fabrication of customizable microneedles enabled by 3D printing for biomedical applications
- A 40-Year-Old Woman With Facial Papules and Flank Pain
- Pathologic Quiz Case: A Nodule on the Back
- Diseases of the Canine Prostate Gland
- Treatment of Cultured Sebocytes with an EGFR Inhibitor Does Not Lead to Significant Upregulation of Inflammatory Biomarkers
- Interdisciplinarity traditional Chinese medicine microneedles in skin disease treatment: Recent advances and challenges
- Trichoblastomas derived from the facial skin with tactile hair in aged house musk shrews (Suncus murinus)
- Poster Presentations
- Nanocarrier Systems for Transdermal Drug Delivery
- New insights into the role of Runx1 in epithelial stem cell biology and pathology
- Docosahexaenoic acid slows inflammation resolution and impairs the quality of healed skin tissue
- Society for Endocrinology Clinical Practice Guideline for the Evaluation of Androgen Excess in Women
- Scalp hypothermia as a preventative measure for chemotherapy‐induced alopecia: a review of controlled clinical trials
- Cancer-Related Alopecia: From Etiologies to Global Management
- Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer
- Loss of TET2 Tips the Scales Toward Tumorigenesis
- Open-Label, Randomized, Multicenter, Phase III Study Comparing Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel in Patients With Metastatic Breast Cancer
- Cancer Chemotherapy: an Introduction